28 September 2021Acasti Pharma (ACST.V) Addresses Unmet SAH Market, Initiates Bridging Study…Kieran Robertson ACST.V Acasti Pharma (ACST.V) announced today that it has initiated its planned pharmacokinetic (PK) bridging study to evaluate the bioavailability of intravenous (IV) GTX-104 compared to oral nimodipine capsules in…